These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12903584)

  • 21. Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
    Dillon MF; McDermott EW; Quinn CM; O'Doherty A; O'Higgins N; Hill AD
    J Surg Oncol; 2006 Jun; 93(7):559-63. PubMed ID: 16705731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
    J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel lymph node biopsy for breast cancer.
    Bold RJ; Schlieman M; Fahy BN
    Cancer Biother Radiopharm; 2001 Oct; 16(5):347-57. PubMed ID: 11776752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ductal Carcinoma In Situ Simultaneously Involving the Breast and Epithelial Inclusions in an Ipsilateral Axillary Lymph Node.
    Commander LA; Ollila DW; O'Connor SM; Hertel JD; Calhoun BC
    Int J Surg Pathol; 2018 Sep; 26(6):564-568. PubMed ID: 29560779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node biopsy for ductal carcinoma in situ: an evolving approach at the University of Florida.
    Camp R; Feezor R; Kasraeian A; Cendan J; Schell S; Wilkinson E; Copeland E; Lind S
    Breast J; 2005; 11(6):394-7. PubMed ID: 16297082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new intraoperative gamma camera for the sentinel lymph node procedure in breast cancer.
    Mathelin C; Salvador S; Bekaert V; Croce S; Andriamisandratsoa N; Liégeois P; Prados E; Guyonnet JL; Grucker D; Brasse D
    Anticancer Res; 2008; 28(5B):2859-64. PubMed ID: 19031925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Day-surgical management of ductal carcinoma in situ (DCIS) of the breast using wide local excision with sentinel node biopsy.
    Buonomo O; Granai AV; Felici A; Piccirillo R; De Liguori Carino N; Guadagni F; Polzoni M; Mariotti S; Cipriani C; Simonetti G; Cossu E; Schiaroli S; Altomare V; Cabassi A; Pernazza E; Casciani CU; Roselli M
    Tumori; 2002; 88(3):S48-9. PubMed ID: 12365390
    [No Abstract]   [Full Text] [Related]  

  • 28. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
    Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
    Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
    van Roozendaal LM; Goorts B; Klinkert M; Keymeulen KBMI; De Vries B; Strobbe LJA; Wauters CAP; van Riet YE; Degreef E; Rutgers EJT; Wesseling J; Smidt ML
    Breast Cancer Res Treat; 2016 Apr; 156(3):517-525. PubMed ID: 27083179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
    Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
    Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous use of an (125)I-seed to guide tumour excision and (99m)Tc-nanocolloid for sentinel node biopsy in non-palpable breast-conserving surgery.
    Pouw B; van der Ploeg IM; Muller SH; Valdés Olmos RA; Janssen-Pinkse LK; Oldenburg HS; Vrancken Peeters MT
    Eur J Surg Oncol; 2015 Jan; 41(1):71-8. PubMed ID: 25458078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
    Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
    Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraoperative, radio-guided sentinel lymph node mapping in 110 nonsmall cell lung cancer patients.
    Rzyman W; Hagen OM; Dziadziuszko R; Kobierska-Gulida G; Karmolinski A; Lothe IM; Babovic A; Murawski M; Paleczka W; Jastrzebski T; Kopacz A; Jassem J; Lass P; Skokowski J
    Ann Thorac Surg; 2006 Jul; 82(1):237-42. PubMed ID: 16798221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of invasive breast cancer in mammographically detected microcalcification in patients with a core biopsy diagnosis of flat epithelial atypia, atypical ductal hyperplasia or ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy.
    Catteau X; Simon P; Noël JC
    Pathol Res Pract; 2012 Apr; 208(4):217-20. PubMed ID: 22445178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
    Tanis PJ; Nieweg OE; Valdés Olmos RA; Hoefnagel CA
    Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):436-7; author reply 437-8. PubMed ID: 12002722
    [No Abstract]   [Full Text] [Related]  

  • 37. Intraoperative detection of sentinel lymph node metastases in breast carcinoma by Fourier transform infrared spectroscopy.
    Tian P; Zhang W; Zhao H; Lei Y; Cui L; Zhang Y; Xu Z
    Br J Surg; 2015 Oct; 102(11):1372-9. PubMed ID: 26198697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Notification of an adverse effect to human albumin (⁹⁹m)Tc-nanocolloid].
    Cotrina-Monroy A; Perez-Iruela JA; Lopez-López A; De Juan R; Rodríguez-Torras ML; Gómez Embuena A
    Rev Esp Med Nucl; 2010; 29(6):308-9. PubMed ID: 20880609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel node biopsy and concomitant probe-guided tumor excision of nonpalpable breast cancer.
    van Rijk MC; Tanis PJ; Nieweg OE; Loo CE; Olmos RA; Oldenburg HS; Rutgers EJ; Hoefnagel CA; Kroon BB
    Ann Surg Oncol; 2007 Feb; 14(2):627-32. PubMed ID: 17151797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.
    Maza S; Thomas A; Winzer KJ; Hüttner C; Blohmer JU; Hauschild M; Richter M; Krössin T; Geworski L; Zander A; Guski H; Munz DL
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):671-5. PubMed ID: 14745517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.